Copyright
©The Author(s) 2024.
World J Gastroenterol. Dec 28, 2024; 30(48): 5152-5161
Published online Dec 28, 2024. doi: 10.3748/wjg.v30.i48.5152
Published online Dec 28, 2024. doi: 10.3748/wjg.v30.i48.5152
Table 2 Baseline endoscopic findings in the study patients, n (%)
| Rebamipide/nizatidine (n = 121) | Nizatidine (n = 118) | P value | |
| Erosion | 0.784 | ||
| 1 (no erosion) | 0 (0) | 0 (0) | |
| 2 (1-2 erosions) | 42 (34.7) | 46 (39.0) | |
| 3 (3-5 erosions) | 43 (35.5) | 40 (33.9) | |
| 4 (> 5 erosions) | 36 (29.8) | 32 (27.1) | |
| Edema | 0.379 | ||
| 1 (none) | 86 (71.1) | 90 (76.9) | |
| 2 (pale/whiter and slightly accentuated hexagonal area gastric pattern) | 35 (28.9) | 27 (23.1) | |
| Redness | 0.906 | ||
| 1 (none) | 35 (28.9) | 31 (26.5) | |
| 2 (minimal but obvious change) | 74 (61.2) | 74 (63.2) | |
| 3 (conspicuous patchy discoloration) | 11 (9.1) | 10 (8.5) | |
| 4 (color change is beefy-red in intensity) | 1 (0.8) | 2 (1.7) | |
| Hemorrhage | 0.622 | ||
| 1 (none) | 86 (71.1) | 77 (65.8) | |
| 2 (1 hemorrhagic lesion) | 15 (12.4) | 17 (14.5) | |
| 3 (2-5 hemorrhagic lesions) | 15 (12.4) | 20 (17.1) | |
| 4 (> 6 hemorrhagic lesions) | 5 (4.1) | 3 (2.6) |
- Citation: Kang D, Choi MG, Shim KN, Jung HK, Nam SJ, Park JH, Kim SG, Kim NH, Hong SJ, Jeon TJ, Chung JI, Lee HL, Lee JY, Kim TO, Lee CM, Kim SM, Kim JH, Kim JE, Moon JS, Kim HD, Lee WS, Park HJ. Efficacy and safety of rebamipide/nizatidine in patients with erosive gastritis: A randomized, multicenter, phase 4 study. World J Gastroenterol 2024; 30(48): 5152-5161
- URL: https://www.wjgnet.com/1007-9327/full/v30/i48/5152.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i48.5152